Samsung and top US hospital team up to study GLP-1 drugs using Galaxy Watch. Why is it necessary for you?

India, May 31 -- Samsung Electronics and Massachusetts General Hospital (MGH) Diabetes Research Center (DRC) today jointly ...

Samsung, Mass General study Galaxy Watch for GLP-1 patients

The six-month clinical study will enroll 100 adults starting weight-loss drug therapy to test whether smartwatch data can help manage muscle loss ...
Becker's Hospital Review

Samsung, Massachusetts General Hospital test wearable tech for GLP-1 patients

Samsung Electronics and Boston-based Massachusetts General Hospital’s Diabetes Research Center are launching a clinical study to evaluate whether the Galaxy Watch8 can help adults beginning GLP-1 ...

Samsung is using Galaxy Watch 8 to study what Ozempic, other GLP-1 drugs might secretly do to you

Samsung is using the Galaxy Watch 8 to examine users of Ozempic and other GLP-1 weight-loss drugs and offer personalized ...

Samsung Is Testing Galaxy Watch 8 To Prevent Muscle Loss On GLP-1s Like Ozempic

Samsung has teamed up with diabetes experts at Massachusetts General Hospital to see how Galaxy Watch 8 can help prevent muscle loss in GLP-1 patients.
EurekAlert!

AI-based monitoring reveals protein deficiencies in people taking GLP-1 receptor agonists for weight loss

Adults with overweight or obesity taking the new generation of weight loss drugs semaglutide and tirzepatide tend to eat significantly less, leaving them vulnerable to nutritional deficiencies, ...